Company / Current Liabilities per Share
Bioventus Inc. Current Liabilities per Share History
FY2021-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Current Liabilities per Share
$2.56
FY2025
5-year range
$2.56 / $6.69
FY2021-FY2025
Trend
-25.3%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Current Liabilities per Share has declined for 3 consecutive years, from $6.69 in FY2022 to $2.56 in FY2025.
Based on SEC 10-K filings.
2.56 in FY2025 with a 3-year CAGR of -27.4%.
Improved from $3.86 to $2.56 over the past 2 years.
Current Liabilities per Share over time
Growth rates
- 3-Year CAGR
- -27.4%
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- Bioventus Inc.'s current liabilities per share has declined for 3 consecutive years.
- In FY2025, current liabilities per share decreased 25.3% year-over-year.
- Peak current liabilities per share was recorded in FY2022.
Company context
Key Data Points
- High Piotroski F-Score: 8/9 (strong financial health signals)
- Altman Z-Score 0.93 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Current Liabilities per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $2.56 | -25.3% |
| FY2024 | $3.43 | -11.2% |
| FY2023 | $3.86 | -42.3% |
| FY2022 | $6.69 | +68.1% |
| FY2021 | $3.98 | - |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026